Wikisage, the free encyclopedia of the second generation, is digital heritage

XR-topiramate

From Wikisage
Revision as of 01:57, 11 November 2016 by Penarc (talk | contribs) (Created page with "'''Qudexy XR''' was approved by FDA on March 2014. It is effective on partial onset seisure once daily schedule<ref>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409552/pdf/1...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Qudexy XR was approved by FDA on March 2014. It is effective on partial onset seisure once daily schedule[1]

  1. ↑ A review of the efficacy and safety of extended-release topiramate in the adjunctive treatment for refractory partial-onset seizures
Retrieved from "https://en.wikisage.org/w/index.php?title=XR-topiramate&oldid=5149"